Combined antipyschotic prescription for inpatients: A retrospective study;Yatan hastalarda çoklu antipsikotik kullanimi: Geriye dönük bir çalişma

Klinik Psikofarmakoloji Bulteni

Volumn 16, Issue 3, 2006, Pages 167-173

  Böke, Ömer ^a   Sarisoy, Gökhan ^a   Akbaş, Seher ^a   Aker, Servet ^a   Korkmaz, Süleyman ^b   Aker, Arzu Alptekin ^a   Bahçe, Zekeriya ^a   Çelik, Cengiz ^a   Şahin, Ahmet Rifat ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Samsun Ruh Sa li i ve Hastaliklari Hastanesi   (Turkey)

Author keywords

Antipsychotic; Inpatient; Polypharmacy; Schizoaffective; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM; NEUROLEPTIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 33749524235     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schumacher JE, Makela EH, Griffin HR. Multiple antipsychotic medication prescribing patterns. Ann Pharmacother 2003; 37:951-955
2. Paton C, Lelliott P, Harrington M, Okocha C, Sensky T, Duffett R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol 2003; 17:223-229
3. Tapp A, Wood AE, Secrest L, Erdmann J, Cubberley L, Kilzieh N. Combination antipsychotic therapy in clinical practice. Psychiatr Serv 2003; 54:55-59
4. Ito C, Kubota Y, Sato M. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia. Psychiatry and Clin Neurosci 1999; 53(Suppl): S35-S40
5. Takei N, Inagaki A. Polypharmacy for psychiatric treatments in Japan. Lancet 2002; 360: 647
6. Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: Case control study of risk versus benefits. Am J Psychiatry 2004; 161: 700-706
7. Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005; 5: 26
8. Waddington JL, Youssef HA, Kinsella A. Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. Br J Psychiatry 1998; 173: 325-329
9. Ensari H, Ceylan ME, Kilinç E, Kenar J. Türkiye'deki ruh hastaliklari hastanelerindeki psikofarmakolojik tedavilerin kalite yönünden deǧerlendirilmesi. Klinik Psikofarmakoloji Bülteni 2004; 14: 68-78
10. Parepally H, Chakravorty S, Levine J, Bar JS, Patel AM, Baird JW, Chalasani L, Delaney JA, Atzert R, Chengappa KN. The use of concomitant medications in psychatric inpatients treated with either olanzapine or other antipsychotic agents A naturalistic study at a state psychiatric hospital. Prog Neuro-Psychopharmacol Biol Psychiatry 2002; 26: 437-440
11. McCue RE, Waheed R, Urcuyo L. Polipharmacy in Patients with Schizophrenia. J Clin Psychiatry 2003; 64: 984-989
12. Jahnssen B, Weinmann S, Berger M, Gaebel W. Validation of polypharmacy process measures in inpatient schizophrenic care. Schizophrenia Bull 2004; 30: 1023-1032
13. Ananth J, Parameswaran S, Gunatikale S. Antipsychotic polypharmacy. Curr Pharm Des 2004; 10: 2231-2238
14. Ito H, Koyama A, Higuchi T. Polypharmacy and exessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br Psychiatry 2005; 187: 243-247
15. Rittmansberger H, Melse U, Schauflinger K, Horvath E, Donat H, Hinterhuber H. Polypharmacy in psychiatric treatment: patterns of psychotropic drug use in Austrian psychiatric clinics. Eur Psychiatry 1999; 14:33- 40
16. Edlinger M, Hausmann A, Kemmler G, Kurz M, Kurtzhaler I, Wlach T, Walpoth M, Fleischhacker W. Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period. Schizophrenia Research 2005; 77:25-34
17. Sim K, Su A, Fujii S, Yang S, Chong M, Ungvari G, Si T, Chung E, Tsang H, Chan Y, Hecker S, Shinfuku N, Tan C. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. British J Clin Pharmacology 2004; 58: 178-183
18. Gordos G. Antipsychotic polypharmacy or monotherapy? Neuropsychopharmacol Hung 2005; 7: 72-77
19. Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61: 9-15
20. Pirildar Ş. Şizofrenide Ekleme Tedavileri. Şizofreni Tedavi Kilavuzu içinde, Alptekin K, Atbaşoǧlu (Editörler), 1. Baski, Ankara: Pozitif Matbaacilik Ltd. Şti., 2005 23-28